593 related articles for article (PubMed ID: 24103427)
21. Rapid detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis by the direct thin-layer agar method.
Robledo J; Mejia GI; Paniagua L; Martin A; Guzmán A
Int J Tuberc Lung Dis; 2008 Dec; 12(12):1482-4. PubMed ID: 19017461
[TBL] [Abstract][Full Text] [Related]
22. Synthesis of novel 1,2,3-triazole derivatives of isoniazid and their in vitro and in vivo antimycobacterial activity evaluation.
Kumar D; Beena ; Khare G; Kidwai S; Tyagi AK; Singh R; Rawat DS
Eur J Med Chem; 2014 Jun; 81():301-13. PubMed ID: 24852277
[TBL] [Abstract][Full Text] [Related]
23. Rapid and simple MTT method for rifampicin and isoniazid susceptibility testing of Mycobacterium tuberculosis.
Foongladda S; Roengsanthia D; Arjrattanakool W; Chuchottaworn C; Chaiprasert A; Franzblau SG
Int J Tuberc Lung Dis; 2002 Dec; 6(12):1118-22. PubMed ID: 12546122
[TBL] [Abstract][Full Text] [Related]
24. [Emergent strains of rifampicin-resistant Mycobacterium tuberculosis complex and susceptibility to isoniazid].
Cacho-Calvo J; Martín-Díaz A;
Enferm Infecc Microbiol Clin; 2013; 31(7):486-7. PubMed ID: 23623580
[No Abstract] [Full Text] [Related]
25. 3'-bromo analogues of pyrimidine nucleosides as a new class of potent inhibitors of Mycobacterium tuberculosis.
Shakya N; Srivastav NC; Desroches N; Agrawal B; Kunimoto DY; Kumar R
J Med Chem; 2010 May; 53(10):4130-40. PubMed ID: 20420370
[TBL] [Abstract][Full Text] [Related]
26. In vitro activity of isoimperatorin, alone and in combination, against Mycobacterium tuberculosis.
Guo N; Wu J; Fan J; Yuan P; Shi Q; Jin K; Cheng W; Zhao X; Zhang Y; Li W; Tang X; Yu L
Lett Appl Microbiol; 2014 Apr; 58(4):344-9. PubMed ID: 24330002
[TBL] [Abstract][Full Text] [Related]
27. Detection of rifampicin and isoniazid resistances of Mycobacterium tuberculosis strains by particle counting immunoassay (PACIA).
Drowart A; Cambiaso CL; Huygen K; Serruys E; Portaels F; Jann E; Van Vooren JP
Int J Tuberc Lung Dis; 1997 Jun; 1(3):284-8. PubMed ID: 9432378
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis and antimycobacterial evaluation of novel 3-substituted-N-aryl-6,7-dimethoxy-3a,4-dihydro-3H-indeno[1,2-c]pyrazole-2-carboxamide analogues.
Ahsan MJ; Samy JG; Dutt KR; Agrawal UK; Yadav BS; Vyas S; Kaur R; Yadav G
Bioorg Med Chem Lett; 2011 Aug; 21(15):4451-3. PubMed ID: 21733688
[TBL] [Abstract][Full Text] [Related]
29. Facile synthesis and antimycobacterial activity of isoniazid, pyrazinamide and ciprofloxacin derivatives.
Alsayed SSR; Lun S; Payne A; Bishai WR; Gunosewoyo H
Chem Biol Drug Des; 2021 Jun; 97(6):1137-1150. PubMed ID: 33638304
[TBL] [Abstract][Full Text] [Related]
30. Performance of the genotype MTBDR line probe assay for detection of resistance to rifampin and isoniazid in strains of Mycobacterium tuberculosis with low- and high-level resistance.
Brossier F; Veziris N; Truffot-Pernot C; Jarlier V; Sougakoff W
J Clin Microbiol; 2006 Oct; 44(10):3659-64. PubMed ID: 17021094
[TBL] [Abstract][Full Text] [Related]
31. [A study of INH 0.1 microgram/ml resistant M. tuberculosis strains assessed by BrothMIC MTB-1 method].
Yoshida H; Ano H; Ishida C; Tanigawa N; Kikui M; Takashima T; Tsuyuguchi I
Kekkaku; 2002 Jul; 77(7):533-5. PubMed ID: 12187818
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens.
Hillemann D; Rüsch-Gerdes S; Richter E
J Clin Microbiol; 2007 Aug; 45(8):2635-40. PubMed ID: 17537937
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and antimycobacterial activity of a novel series of isonicotinylhydrazide derivatives.
Jaju S; Palkar M; Maddi VS; Ronad P; Mamledesai S; Satyanarayana D; Ghatole M
Arch Pharm (Weinheim); 2009 Dec; 342(12):723-31. PubMed ID: 19899098
[TBL] [Abstract][Full Text] [Related]
34. Antimycobacterial susceptibility evaluation of rifampicin and isoniazid benz-hydrazone in biodegradable polymeric nanoparticles against
Hakkimane SS; Shenoy VP; Gaonkar SL; Bairy I; Guru BR
Int J Nanomedicine; 2018; 13():4303-4318. PubMed ID: 30087562
[TBL] [Abstract][Full Text] [Related]
35. Lower cytotoxicity, high stability, and long-term antibacterial activity of a poly(methacrylic acid)/isoniazid/rifampin nanogel against multidrug-resistant intestinal Mycobacterium tuberculosis.
Chen T; Li Q; Guo L; Yu L; Li Z; Guo H; Li H; Zhao M; Chen L; Chen X; Zhong Q; Zhou L; Wu T
Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():659-65. PubMed ID: 26478357
[TBL] [Abstract][Full Text] [Related]
36. Bis dihydropyrimidine: synthesis and antimycobacterial activity.
Ali MA; Manogaran E; Govindasamy J; Sellappan V; Pandian S
J Enzyme Inhib Med Chem; 2011 Feb; 26(1):149-53. PubMed ID: 20583864
[TBL] [Abstract][Full Text] [Related]
37. [The resistance rates of Mycobacterium tuberculosis strains to antituberculosis drugs: evaluation of two years' data in Aegean region, Turkey].
Güneri S; Unsal I; Oztop A; Erkut M; Avkan Oğuz V; Ozgü A; Cakmak R
Mikrobiyol Bul; 2004 Jul; 38(3):203-12. PubMed ID: 15490839
[TBL] [Abstract][Full Text] [Related]
38. Validation of a rapid method for detection of M. tuberculosis resistance to INH and RMP in Lima, Peru.
De Kantor IN
Int J Tuberc Lung Dis; 2006 Jun; 10(6):707; author reply 707-8. PubMed ID: 16776461
[No Abstract] [Full Text] [Related]
39. Insights on the Mechanism of Action of INH-C
Vila-Viçosa D; Victor BL; Ramos J; Machado D; Viveiros M; Switala J; Loewen PC; Leitão R; Martins F; Machuqueiro M
Mol Pharm; 2017 Dec; 14(12):4597-4605. PubMed ID: 29091448
[TBL] [Abstract][Full Text] [Related]
40. Rapid phenotypic assay of antimycobacterial susceptibility pattern by direct mycobacteria growth indicator tube and phage amplified biological assay compared to BACTEC 460 TB.
El-Sayed Zaki M; Goda T
Tuberculosis (Edinb); 2007 Mar; 87(2):102-8. PubMed ID: 17035089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
